Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Standard of Care × NET × 1 year × Clear all

Sponsor

Cancer Type

Breast 41 Genitourinary 39 Gastrointestinal 38 Thoracic 29 Other hematologic neoplasm 20 Tumor-Agnostic 18 Head & Neck 18 Other solid neoplasm 16 Lymphoid 12 Gynecologic 12 Plasma cell 10 Sarcoma 8 CNS 8 Dermatologic 7 Other 4 Myeloid 2 Endocrine 2 Other neoplasm 1

Interventions

lutetium Lu 177 dotatate 25 Magnetic Resonance Spectroscopy 14 Everolimus 11 Specimen Handling 9 pembrolizumab 7 Nivolumab 7 cabozantinib 5 Octreotide 5 Capecitabine 5 177Lu-octreotide, DOTA(0)-Tyr(3)- 5 surufatinib 4 gallium Ga 68 dotatate 4 amino-acid, glucose, and electrolyte solution 4 Ipilimumab 4 Injections 4 Fluorodeoxyglucose F18 4 lenvatinib 3 X-Rays 3 Temozolomide 3 Cyclophosphamide 3 Carboplatin 3 tislelizumab 2 pasireotide 2 olaparib 2 lanreotide 2 fludarabine phosphate 2 fludarabine 2 copper dotatate CU-64 2 atezolizumab 2 Surveys and Questionnaires 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡